You make perfect sense.
However, as I’m neither a physician nor PKD patient I’m not qualified to speculate.
I can only imagine that changes in protein expression would be seen before subjective reports of better health. But I could be wrong.
- Forums
- ASX - By Stock
- PYC
- Ann: First Subject Dosed in PKD Clinical Trial
PYC
pyc therapeutics limited
Add to My Watchlist
0.00%
!
$1.19

Ann: First Subject Dosed in PKD Clinical Trial, page-53
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.19 |
Change
0.000(0.00%) |
Mkt cap ! $691.1M |
Open | High | Low | Value | Volume |
$1.19 | $1.20 | $1.19 | $7.366K | 6.164K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17309 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 3653 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17309 | 1.190 |
1 | 3310 | 1.185 |
2 | 3710 | 1.180 |
1 | 3310 | 1.175 |
4 | 77891 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 3653 | 2 |
1.205 | 2625 | 3 |
1.210 | 1668 | 3 |
1.215 | 814 | 1 |
1.220 | 5559 | 4 |
Last trade - 10.37am 16/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |